Preprint Article Version 1 This version is not peer-reviewed

How to Analyze Cancer Progression in COVID-19 Pandemic?

Version 1 : Received: 16 May 2020 / Approved: 17 May 2020 / Online: 17 May 2020 (08:50:22 CEST)

How to cite: Bhattacharjee, A.; Vishwakarma, G.K.; Banerjee, S.; Shukla, S. How to Analyze Cancer Progression in COVID-19 Pandemic?. Preprints 2020, 2020050288 (doi: 10.20944/preprints202005.0288.v1). Bhattacharjee, A.; Vishwakarma, G.K.; Banerjee, S.; Shukla, S. How to Analyze Cancer Progression in COVID-19 Pandemic?. Preprints 2020, 2020050288 (doi: 10.20944/preprints202005.0288.v1).

Abstract

The constant news about the corona virus is scary. It is not possible to separate treatment for Cancer due to COVID-19. An effective treatment comparison strategy is needed. We need to have a handy tool to understand cancer progression in this unprecedented scenario. Linking different events of cancer progression is the need of the hour. It is a methodological challenge. We provide the solutions to overcome the issue with interval between two consecutive events in motivating head and neck cancer (HNC) data.

Subject Areas

COVID-19; Accelerated Failure Time; Proportional Hazard Model; Bayesian; Auto-Regression

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.